FindTrial
Sign In

A prospective cohort study on the efficacy and safety of bilateral abdominal wall suspension for the treatment of pelvic prolapse in women

A prospective cohort study on the efficacy and safety of bilateral abdominal wall suspension for the treatment of pelvic prolapse in women

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100051858
Enrollment
Unknown
Registered
2021-10-07
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pelvic organ prolapse

Interventions

Experimental group:Treatment of pelvic organ prolapse with laparoscopic bilateral abdominal wall suspension
Control group:Transvaginal mesh reconstruction for treatment of pelvic organ prolapse

Sponsors

Shanghai Tongji Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
35 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 35 to 85 years; 2. The POP-Q (pelvic organ prolapse-quantification) score of uterine or vaginal stump prolapse > stage II and affects the patient's daily life; 3. Those who agree to participate in the trial and can cooperate with examination and treatment; 4. Can communicate with researchers.

Exclusion criteria

Exclusion criteria: 1. Patients with acute infection; 2. Those with more serious liver and kidney, heart, blood, neurological diseases, and diabetes; 3. Malignant tumor; 4. Those with mental or mental illness; 5. Users of drugs that affect blood coagulation function.

Design outcomes

Primary

MeasureTime frame
Effective rate;—

Secondary

MeasureTime frame
Quality of life;Lower urinary tract impact;—

Countries

China

Contacts

Public ContactChu Lei

Shanghai Tongji Hospital

chulei1982@yeah.net+86 13764427321

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026